Nonprofit research institute ES

CIC biomaGUNE

Papers we track 692
Since 1996
Most active in Gold and Silver Nanoparticles for Cancer Therapy, Imaging, and Biosensing

Research trend rank among all institutions in Europe, by papers, per year

lower coverage before 2010 #1 #1,732 #3,464 2000 2010 2020 1996: #2,133 of 3,386 1997: #2,366 of 3,482 1998: #2,996 of 3,663 2000: #3,225 of 3,579 2007: #3,267 of 4,385 2008: #3,464 of 4,596 2009: #1,277 of 4,916 2010: #1,368 of 5,158 2011: #2,716 of 4,933 2012: #1,909 of 5,656 2013: #633 of 6,296 2014: #677 of 6,943 2015: #713 of 7,571 2016: #817 of 7,910 2017: #605 of 5,800 2018: #692 of 4,797 2019: #840 of 5,456 2020: #1,350 of 11,267 2021: #1,227 of 11,402 2022: #1,361 of 10,914 2023: #1,410 of 10,918 2024: #1,339 of 10,911 2025: #1,235 of 11,401 2026: #1,278 of 8,706 — year in progress

Each point is this institution's position that year among all institutions in Europe, by papers, with credit split across co-authoring institutions. #1 is at the top. Hover a point for the figures. The hollow point is the year in progress.

Where it works most top research communities, by papers

Check communities to show the trend above for them only. Positions are by fractional papers across all years. A community page ranks its institutions by citation-weighted credit, so its order can differ.

Covers the materials and chemistry research Elements Live tracks, not everything CIC biomaGUNE publishes. Institutions come from OpenAlex affiliations, rolled up to the parent organisation. Older papers often lack affiliations, so earlier years undercount.